Biography:
Dr. Paul completed his PhD from the University of British Columbia and postdoctoral studies from Memorial Sloan-Kettering Cancer Center. He is a Professor of Pharmacology and Experimental Therapeutics, and Chief Science Officer of Oleander Medical Technologies, a Biotech company established to advance the TOL technology. He has published more than 70 papers in reputed journals and has been serving as an editorial board member of the Journal of the Neurological Sciences and the Encyclopaedia of the Neurological Sciences.